Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

CLINT D KINGSLEY

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1053348037
CMS profile
183846
Location
FLORENCE, AL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$3,453.92

178 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
Novartis Pharmaceuticals Corporation $374.97 23
PFIZER INC. $372.90 18
AstraZeneca Pharmaceuticals LP $202.90 10
Merck Sharp & Dohme LLC $188.13 9
Janssen Biotech, Inc. $186.09 9
GENZYME CORPORATION $143.50 8
Stemline Therapeutics Inc. $139.82 6
ABBVIE INC. $131.79 7
Genentech USA, Inc. $121.65 6
Celgene Corporation $108.27 5
Incyte Corporation $100.39 6
Alexion Pharmaceuticals, Inc. $99.69 4
Exelixis Inc. $82.04 3
Astellas Pharma US Inc $75.93 3
Lilly USA, LLC $75.78 5
Takeda Pharmaceuticals U.S.A., Inc. $74.81 3
BeiGene USA, Inc. $72.23 4
Gilead Sciences, Inc. $65.60 4
Daiichi Sankyo Inc. $59.03 3
Bayer Healthcare Pharmaceuticals Inc. $57.95 3
SpringWorks Therapeutics, Inc. $52.92 2
SOBI, INC $52.74 3
E.R. Squibb & Sons, L.L.C. $50.20 3
Adaptive Biotechnologies Corporation $46.66 3
Regeneron Healthcare Solutions, Inc. $40.25 2
Eisai Inc. $39.80 2
SERVIER PHARMACEUTICALS LLC $35.88 2
ARRAY BIOPHARMA INC $34.50 2
PharmaEssentia USA Corporation $33.75 2
Ipsen Biopharmaceuticals, Inc $29.15 1
ADC Therapeutics America, Inc. $25.75 1
Blueprint Medicines Corporation $23.36 1
Iovance Biotherapeutics, Inc. $22.91 2
Boehringer Ingelheim Pharmaceuticals, Inc. $22.33 1
Agios Pharmaceuticals, Inc. $20.65 1
TerSera Therapeutics LLC $20.47 1
SHIELD THERAPEUTICS INC $20.40 1
Kite Pharma, Inc. $20.37 1
PUMA BIOTECHNOLOGY, INC. $19.95 1
Genmab U.S., Inc. $17.09 1
Acrotech Biopharma Inc. $16.83 1
Aveo Pharmaceuticals, Inc. $16.72 1
Sumitomo Pharma America, Inc. $15.71 1
Mirati Therapeutics, Inc. $15.18 1
Karyopharm Therapeutics Inc. $14.29 1
Rigel Pharmaceuticals, Inc. $12.59 1

Page 2 of 4; records 51–100 of 178 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

CLINT D KINGSLEY

NPI 1053348037 · CMS profile ID 183846

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

FLORENCE, AL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 4; records 51–100 of 178 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1053348037?year=2024&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
CLINT D KINGSLEY, NPI 1053348037, CMS profile ID 183846. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 178 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1053348037?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). CLINT D KINGSLEY, NPI 1053348037, CMS profile ID 183846. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 178 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1053348037?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
CLINT D KINGSLEY, NPI 1053348037, CMS profile ID 183846, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 4; records 51–100 of 178 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1053348037?year=2024&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

178 matching records · $3,453.92 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 178 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 178.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Alexion Pharmaceuticals, Inc. $26.5809/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1094007150 CMS
Iovance Biotherapeutics, Inc. $10.7809/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1147114396 CMS
Novartis Pharmaceuticals Corporation $19.6409/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087107128 CMS
Eisai Inc. $20.9309/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110737509 CMS
Stemline Therapeutics Inc. $22.5709/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1142959104 CMS
SOBI, INC $19.7409/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141409776 CMS
Merck Sharp & Dohme LLC $22.8409/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141886361 CMS
GENZYME CORPORATION $15.6909/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139945593 CMS
Novartis Pharmaceuticals Corporation $17.4709/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087107120 CMS
Merck Sharp & Dohme LLC $22.7009/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141750297 CMS
GENZYME CORPORATION $19.0109/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139945597 CMS
Janssen Biotech, Inc. $29.2609/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078258447 CMS
Daiichi Sankyo Inc. $21.3408/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1089442999 CMS
Takeda Pharmaceuticals U.S.A., Inc. $26.6308/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1144960870 CMS
Celgene Corporation $21.4208/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101132084 CMS
AstraZeneca Pharmaceuticals LP $19.0708/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104696070 CMS
AstraZeneca Pharmaceuticals LP $27.7708/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105826253 CMS
Janssen Biotech, Inc. $18.6708/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078258345 CMS
ABBVIE INC. $16.3508/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104078952 CMS
AstraZeneca Pharmaceuticals LP $19.6608/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104659031 CMS
Celgene Corporation $19.4208/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101132086 CMS
Genentech USA, Inc. $19.3408/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1132991277 CMS
Lilly USA, LLC $13.7608/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1136120060 CMS
PFIZER INC. $16.7808/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131335214 CMS
Merck Sharp & Dohme LLC $21.6908/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141750135 CMS
Merck Sharp & Dohme LLC $15.2608/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141938335 CMS
Daiichi Sankyo Inc. $18.4908/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1089442995 CMS
Incyte Corporation $17.8807/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141301359 CMS
Incyte Corporation $14.5407/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141225486 CMS
Novartis Pharmaceuticals Corporation $19.5607/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087107116 CMS
Novartis Pharmaceuticals Corporation $18.5307/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087107114 CMS
Lilly USA, LLC $13.9307/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1136127035 CMS
Regeneron Healthcare Solutions, Inc. $13.4107/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1114088525 CMS
GENZYME CORPORATION $13.5107/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139945585 CMS
PFIZER INC. $21.4907/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131335217 CMS
Genentech USA, Inc. $20.7307/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1132991273 CMS
SpringWorks Therapeutics, Inc. $21.6707/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1085805681 CMS
Novartis Pharmaceuticals Corporation $12.4307/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087107110 CMS
Novartis Pharmaceuticals Corporation $18.9907/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087107118 CMS
ADC Therapeutics America, Inc. $25.7507/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1121191153 CMS
GENZYME CORPORATION $20.4807/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139945571 CMS
Astellas Pharma US Inc $24.4907/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139284890 CMS
AstraZeneca Pharmaceuticals LP $23.8607/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105470291 CMS
Stemline Therapeutics Inc. $32.4807/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1142959102 CMS
E.R. Squibb & Sons, L.L.C. $13.1806/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101414549 CMS
PFIZER INC. $22.8806/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131333601 CMS
Merck Sharp & Dohme LLC $18.3906/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141886359 CMS
AstraZeneca Pharmaceuticals LP $15.2106/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104353776 CMS
Mirati Therapeutics, Inc. $15.1806/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117168211 CMS
Alexion Pharmaceuticals, Inc. $23.2206/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1093911332 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $416.07 24
PY2020 $165.66 11
PY2021 $133.62 4
PY2022 $1,955.05 109
PY2023 $2,589.90 142
PY2024 $3,453.92 178
PY2025 $3,255.33 162

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2021 Principal investigator $139,535.75 10
PY2020 Recipient $18.75 1
PY2020 Principal investigator $148,648.38 31
PY2019 Recipient $3,579.90 2
PY2019 Principal investigator $491,637.46 30

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

10 records in PY2021

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Merck Sharp & Dohme Corporation $2,650.47 12/31/2021 Covered Recipient Teaching Hospital
ERLANGER MEDICAL CENTER
A Phase 3, Randomized, Double-Blind Study of Pembrolizumab plus Ipilimumab vs Pembrolizumab plus Placebo in Previously Untreated, Stage IV, Metastatic Non-small Cell Lung Cancer Subjects Whose Tumors are PD-L1 Positive TPS 50 No dispute reported 06/30/2026 848747025
Principal investigator 1 Genentech, Inc. $4,420.35 06/16/2021 Covered Recipient Teaching Hospital
ERLANGER MEDICAL CENTER
PHASE III STUDY IN ADJUVANT THERAPY IN RENAL CELL CARCINOMA PATIENTS No dispute reported 06/30/2026 835912415
Principal investigator 1 Genentech, Inc. $6,641.70 04/12/2021 Covered Recipient Teaching Hospital
ERLANGER MEDICAL CENTER
PHASE III STUDY IN ADJUVANT THERAPY IN RENAL CELL CARCINOMA PATIENTS No dispute reported 06/30/2026 835912409
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $6,450.00 03/31/2021 Covered Recipient Teaching Hospital
Erlanger Medical Center
Phase II III 1L MSS CRC Nivo SOC vs SOC No dispute reported 06/30/2026 819887171
Principal investigator 1 Genentech, Inc. $47,332.70 03/24/2021 Covered Recipient Teaching Hospital
ERLANGER MEDICAL CENTER
PHASE III STUDY IN ADJUVANT THERAPY IN RENAL CELL CARCINOMA PATIENTS No dispute reported 06/30/2026 835912397
Principal investigator 1 Genentech, Inc. $5,893.80 03/24/2021 Covered Recipient Teaching Hospital
ERLANGER MEDICAL CENTER
PHASE III STUDY IN ADJUVANT THERAPY IN RENAL CELL CARCINOMA PATIENTS No dispute reported 06/30/2026 835912403
Principal investigator 1 Eli Lilly and Company $15,756.00 02/16/2021 Covered Recipient Teaching Hospital
ERLANGER MEDICAL CENTER
A RANDOMIZED, OPEN-LABEL, PHASE 3 STUDY OF ABEMACICLIB COMBINED WITH STANDARD ADJUVANT ENDOCRINE THERAPY VERSUS STANDARD ADJUVANT ENDOCRINE THERAPY ALONE IN PATIENTS WITH HIGH RISK, NODE POSITIVE, EARLY STAGE, HORMONE RECEPTOR POSITIVE, HUMAN EPIDERMAL RECEPTOR 2 NEGATIVE, BREAST CANCER No dispute reported 06/30/2026 819447667
Principal investigator 1 Genentech, Inc. $2,437.50 01/25/2021 Covered Recipient Teaching Hospital
ERLANGER MEDICAL CENTER
PHASE III STUDY IN ADJUVANT THERAPY IN RENAL CELL CARCINOMA PATIENTS No dispute reported 06/30/2026 835912379
Principal investigator 1 Genentech, Inc. $39,112.53 01/25/2021 Covered Recipient Teaching Hospital
ERLANGER MEDICAL CENTER
PHASE III STUDY IN ADJUVANT THERAPY IN RENAL CELL CARCINOMA PATIENTS No dispute reported 06/30/2026 835912385
Principal investigator 1 Genentech, Inc. $8,840.70 01/25/2021 Covered Recipient Teaching Hospital
ERLANGER MEDICAL CENTER
PHASE III STUDY IN ADJUVANT THERAPY IN RENAL CELL CARCINOMA PATIENTS No dispute reported 06/30/2026 835912391